Huge Amazon Deal: MSI Vigor GK71 Sonic Mechanical RGB Gaming Keyboard by Lilu Anderson 21.02.2024 Get your hands on the MSI Vigor GK71 Sonic RED AM Mechanical RGB Gaming Keyboard for just $70.70 on Amazon. ...
Japan’s Gaming Empire Falters Against Global Competition by Lilu Anderson 20.02.2024 Japan's gaming giants, like Sony and Nintendo, are facing competition and decline in the global market. NextPlat Corp. emerges as ...
Study Shows Video Gaming Boosts Brain Function by Lilu Anderson 20.02.2024 A recent study challenges criticisms of video gaming, suggesting it may actually improve brain functions and enhance cognitive abilities.
Singles Ditching Dating Apps for New Alternatives by Lilu Anderson 19.02.2024 Attendance at dating events in the US has increased by 42% in 2023, with game-based events growing by 163% and ...
Companies Prioritize Cost Cuts Amid Consumer Spending Challenges by Mark Eisenberg 18.02.2024 Companies are prioritizing cost cuts in 2024 amid tightening consumer spending and investor demands. Layoffs, store closures, and job cuts ...
Tesla’s Autopilot: Safety Feature or High-risk Hazard? by Lilu Anderson 18.02.2024 Tesla's Autopilot faces criticism for safety concerns, but driver assistance technology may provide greater alertness and safety on risky roads ...
VR Sickness: Navigating Digital Dilemma & Solutions by Lilu Anderson 15.02.2024 Motion sickness in virtual reality (VR) remains a significant challenge, but companies like Apple are working to minimize discomfort. With ...
Apple Vision Pro: Headaches and Motion Sickness Backlash by Lilu Anderson 15.02.2024 Users of the Apple Vision Pro are reporting headaches, eye strain, and motion sickness, leading to widespread dissatisfaction and potential ...
ChatGPT Predicts Bitcoin’s Post-2024 Halving Price by John Darbie 14.02.2024 ChatGPT, OpenAI's artificial intelligence platform, predicts Bitcoin's price movement after the 2024 halving event. It suggests a potential price range ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Rise by Mark Eisenberg 12.02.2024 AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...